share_log

TCR2 Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

SEC announcement ·  Jun 1, 2023 16:44
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more